SUWN Stock Overview
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Sunwin Stevia International, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0003 |
52 Week High | US$0.028 |
52 Week Low | US$0.000001 |
Beta | -0.54 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -96.39% |
3 Year Change | -99.47% |
5 Year Change | -99.35% |
Change since IPO | -98.92% |
Recent News & Updates
Recent updates
Shareholder Returns
SUWN | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -2.2% | -3.7% |
1Y | -96.4% | 11.6% | 20.5% |
Return vs Industry: SUWN underperformed the US Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: SUWN underperformed the US Market which returned 20.2% over the past year.
Price Volatility
SUWN volatility | |
---|---|
SUWN Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SUWN's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SUWN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 242 | Chunchun Wang | www.sunwininternational.com |
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People’s Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components.
Sunwin Stevia International, Inc. Fundamentals Summary
SUWN fundamental statistics | |
---|---|
Market cap | US$59.89k |
Earnings (TTM) | -US$1.62m |
Revenue (TTM) | US$34.00m |
0.0x
P/S Ratio0.0x
P/E RatioIs SUWN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SUWN income statement (TTM) | |
---|---|
Revenue | US$34.00m |
Cost of Revenue | US$29.27m |
Gross Profit | US$4.72m |
Other Expenses | US$6.35m |
Earnings | -US$1.62m |
Last Reported Earnings
Oct 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0081 |
Gross Margin | 13.90% |
Net Profit Margin | -4.77% |
Debt/Equity Ratio | 336.0% |
How did SUWN perform over the long term?
See historical performance and comparison